Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

peppertree

(23,199 posts)
3. True - although Argentina has had three major suppliers (not just Sputnik):
Fri Jul 23, 2021, 12:10 PM
Jul 2021

Of the 40.7 million doses received so far, 13.7 m have been Sinopharm (not Sinovac - the less effective one Brazil, Chile, and Uruguay have been relying on); 11.9 m, Sputnik; 11.7 m, AstraZeneca; and 3.5 m, Moderna (with Pfizer on its way).

Their goal is 63 million, so they still have a ways to go.

Sputnik was the first in Argentina, due to Trump's export ban (and Pfizer's sovereign asset collateral demands) - but has since been eclipsed by these others.

As you pointed out, it also has that problematic 2nd dose - though numerous countries that have received Pfizer have likewise had to combine it with a different 2nd dose for the same reason: availability.

Excluding major vaccine producers (and those who got preferential treatment from Trump very early on - i.e. Israel and the UAE), most countries have faced that same bottleneck.

Thanks for your insightful and informed reply, Eugene (as always). Good chatting again.

Recommendations

0 members have recommended this reply (displayed in chronological order):

Latest Discussions»Region Forums»Latin America»Argentina threatens to ca...»Reply #3